08-02-2018 | Diabetic foot | Article
The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: Results from the LEADER trial
Dhatariya K et al. Diabetes Care 2018: dc181094. doi: 10.2337/dc18-1094
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.
Advertisement